Variable | Adjusted mortality hazardsHR (95%CI) | |
---|---|---|
All patients (n = 203) | Excluding PR Group (n = 185) | |
Age (per year) | 1.05 (1.02-1.08)* | 1.04 (1.01-1.08)* |
CRP (per unit rise) | 1.02 (1.01-1.03)* | 1.02 (1.01-1.03)* |
Duration on dialysis (per month) | 1.01 (1.00-1.01)* | 1.01 (1.00-1.01)* |
Peripheral vascular disease | 1.75 (1.00-3.04)* | 1.80 (0.97-3.25) |
ESA dose | 1.001 (0.996-1.006) | 1.000 (0.997-1.004) |
[Hb] | 1.008 (0.962-1.056) | 0.998 (0.947-1.052) |
LE Group | 0.37 (0.08-1.68) | 0.46 (0.10-2.23) |
GR Group | 1.10 (0.38-3.17) | 1.39 (0.41-4.75) |
HE Group | 0.96 (0.30-3.11) | 1.07 (0.22-5.29) |
PR Group | 1.58 (0.49-5.09) | - |
Test of model assumption | X (4) 2 = 1.00, p = 0.910 | X (4) 2 = 0.33, p = 0.988 |